FDA.reportPublic FDA data

POLYETHYLENE GLYCOL 4000

Substance profile for UNII 4R4HFI6D95, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
4R4HFI6D95
Preferred term
POLYETHYLENE GLYCOL 4000
Registry number
25322-68-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1310594
PubChem
0
NCIt
C84081
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1310594mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1310594
NCI ThesaurusC84081ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C84081
FDA Substance Registration System4R4HFI6D95precision.fda.gov/uniisearch/srs/unii/4R4HFI6D95

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
AMOXICILLIN AND CLAVULANATE POTASSIUM1
AZITHROMYCIN1
LEVETIRACETAM3
Bicaruvas Double Action Antacid1
These highlights do not include all the information needed to use azithromycin tablets safely and effectively. See full prescribing information for azithromycin tablets . AZITHROMYCIN tablets USP for oral use Initial U.S. Approval: 19911
CITALOPRAM HYDROBROMIDE3
Bicaruvas Double Action Antacid4
15fd4cd0-3d68-33ea-e054-00144ff8d46c2
AZITHROMYCIN MONOHYDRATE5
LOSARTAN POTASSIUM TABLETS USP 7364 7365 7366 Rx only17
These highlights do not include all the information needed to use valsartan tablets USP safely and effectively. See full prescribing information for valsartan tablets USP. VALSARTAN tablets USP for oral use Initial U.S. Approval: 19961
These highlights do not include all the information needed to use clopidogrel tablets USP safely and effectively. See full prescribing information for clopidogrel tablets USP. CLOPIDOGREL tablets USP for oral use Initial U.S. Approval: 19974
These highlights do not include all the information needed to use levetiracetam tablets safely and effectively. See full prescribing information for levetiracetam tablets USP. Levetiracetam Tablets USP for Oral Use Initial U.S. Approval: 19992
GEMFIBROZIL TABLETS USP, 600 mg 0670 Rx only5
These highlights do not include all the information needed to use clopidogrel tablets USP safely and effectively. See full prescribing information for clopidogrel tablets USP. CLOPIDOGREL tablets USP for oral use Initial U.S. Approval: 19971
These highlights do not include all the information needed to use Pantoprazole Sodium Delayed-Release Tablets USP safely and effectively. See full prescribing information for Pantoprazole Sodium Delayed-Release Tablets USP. PANTOPRAZOLE Sodium Delayed-Release Tablets USP for oral use Initial U.S. Approval: 20002
e6c92a3f-e194-4f28-bd8c-e1794cd6f4481
These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 20001001
These highlights do not include all the information needed to use levetiracetam tablets safely and effectively. See full prescribing information for levetiracetam tablets. LEVETIRACETAM Tablets USP, for oral use Initial U.S. Approval: 19992
These highlights do not include all the information needed to use donepezil hydrochloride tablets USP safely and effectively. See full prescribing information for donepezil hydrochloride tablets USP. DONEPEZIL hydrochloride tablets USP for oral use Initial U.S. Approval: 19961000
These highlights do not include all the information needed to use levetiracetam tablets safely and effectively. See full prescribing information for levetiracetam tablets. Levetiracetam Tablets USP, for oral use Initial U.S. Approval: 19991
These highlights do not include all the information needed to use donepezil hydrochloride tablets USP safely and effectively. See full prescribing information for donepezil hydrochloride tablets USP. DONEPEZIL hydrochloride tablets USP for oral use Initial U.S. Approval: 19961
DICLOFENAC POTASSIUM TABLETS USP, 50 mg 0948 Rx only1
Drug Facts9
Drug Facts7
FACTIVE ® (gemifloxacin mesylate) Tablets1
These highlights do not include all the information needed to use levetiracetam tablets safely and effectively. See full prescribing information for levetiracetam tablets USP. Levetiracetam Tablets USP for Oral Use Initial U.S. Approval: 19991
Drug Facts3
7d8c8762-e491-4798-8866-0db6425308e82
These highlights do not include all the information needed to use clopidogrel tablets USP safely and effectively. See full prescribing information for clopidogrel tablets USP. CLOPIDOGREL tablets USP for oral use Initial U.S. Approval: 19974
4aad770b-a342-45c5-8199-21a1240603141
These highlights do not include all the information needed to use clopidogrel tablets USP safely and effectively. See full prescribing information for clopidogrel tablets USP. CLOPIDOGREL tablets USP for oral use Initial U.S. Approval: 19971
Levetiracetam1
These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets USP. PANTOPRAZOLE sodium delayed-release tablets USP for oral use Initial U.S. Approval: 20002
Drug Facts2
DICLOFENAC POTASSIUM TABLETS USP, 50 mg 0948 Rx only1
Drug Facts1
Granisetron hydrochloride tablets4
GEMFIBROZIL TABLETS USP, 600 mg Rx only1
DRUG FACTS1
Drug Facts1
drug facts11
These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets, USP safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets, USP. Pantoprazole Sodium Delayed-Release Tablets, USP Initial U.S. approval: 20002
These highlights do not include all the information needed to use ZYPREXA safely and effectively. See full prescribing information for ZYPREXA. ZYPREXA (olanzapine) Tablet for Oral use ZYPREXA ZYDIS (olanzapine) Tablet, Orally Disintegrating for Oral use ZYPREXA IntraMuscular (olanzapine) Injection, Powder, For Solution for Intramuscular use Initial U.S. Approval: 19961
GEMFIBROZIL TABLETS USP, 600 mg Rx only1
DICLOFENAC POTASSIUM TABLETS USP, 50 mg 0948 Rx only1
GEMFIBROZIL TABLETS USP, 600 mg Rx only2
LIFElabs, a Division of Atico International USA, INC.5
GEMFIBROZIL TABLETS USP, 600 mg Rx only1
GEMFIBROZIL TABLETS USP, 600 mg Rx only1
Levetiracetam Tablets1
GEMFIBROZIL TABLETS USP, 600 mg 0670 Rx only1
GEMFIBROZIL TABLETS USP, 600 mg 0670 Rx only1
DICLOFENAC POTASSIUM TABLETS USP, 50 mg 0948 Rx only1
These highlights do not include all the information needed to use bicalutamide tablets USP safely and effectively. See full prescribing information for bicalutamide tablets USP. Bicalutamide Tablets USP for Oral use Initial U.S. Approval: 19951
CLOPIDOGREL TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
LEVETIRACETAM TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
VALSARTAN AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [BRYANT RANCH PREPACK]1000
ZYPREXA (OLANZAPINE) TABLET ZYPREXA ZYDIS (OLANZAPINE) TABLET, ORALLY DISINTEGRATING ZYPREXA INTRAMUSCULAR (OLANZAPINE) INJECTION, POWDER, FOR SOLUTION [ELI LILLY AND COMPANY ]45
SIMVASTATIN TABLET, FILM COATED [INTERNATIONAL LABORATORIES, INC.]32
SEROQUEL XR (QUETIAPINE FUMARATE) TABLET, EXTENDED RELEASE SEROQUEL XR (QUETIAPINE FUMARATE) KIT [ASTRAZENECA PHARMACEUTICALS LP]30
INVEGA SUSTENNA (PALIPERIDONE PALMITATE) INJECTION [JANSSEN PHARMACEUTICALS, INC.]19
BENAZEPRIL TABLET, COATED [INTERNATIONAL LABORATORIES, INC.]18
QUETIAPINE FUMARATE TABLET QUETIAPINE FUMARATE (QUETIAPINE FUMARATE ) TABLET [ASCEND LABORATORIES, LLC]18
SIMVASTATIN TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]17
TROSPIUM CHLORIDE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]16
DIVALPROEX SODIUM TABLET, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC]15
LEVETIRACETAM TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]15
BENAZEPRIL HYDROCHLORIDE TABLET, COATED [TEVA PHARMACEUTICALS USA INC]14
LOSARTAN POTASSIUM TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]14
CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE) TABLET [PD-RX PHARMACEUTICALS, INC.]13
CITALOPRAM HYDROBROMIDE TABLET [SUN PHARMACEUTICAL INDUSTRIES, INC.]13
QUETIAPINE FUMARATE TABLET, FILM COATED [SUN PHARMA GLOBAL FZE]12
FAMOTIDINE TABLET, FILM COATED [IVAX PHARMACEUTICALS, INC.]11
LEVETIRACETAM TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]11
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]11
PANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC]11
TOPIRAMATE TABLET [TEVA PHARMACEUTICALS USA INC]11
AZITHROMYCIN TABLET, FILM COATED [PLIVA, INC.]10
GEMFIBROZIL TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]10
MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [UPSHER-SMITH LABORATORIES, INC.]10
VALGANCICLOVIR (VALGANCICLOVIR HYDROCHLORIDE) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]10
CITALOPRAM HYDROBROMIDE TABLET [PD-RX PHARMACEUTICALS, INC.]9
LEVETIRACETAM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]9
CLARITHROMYCIN TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC]8
CLOPIDOGREL TABLET, FILM COATED [INTERNATIONAL LABORATORIES, INC.]8
LEVETIRACETAM TABLET, FILM COATED [LUPIN PHARMACEUTICALS, INC.]8
LEVETIRACETAM TABLET, FILM COATED [NORTHSTAR RX LLC]8
TRAMADOL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]8
CEFUROXIME AXETIL TABLET [LUPIN PHARMACEUTICALS, INC.]7
CITALOPRAM HYDROBROMIDE TABLET [PD-RX PHARMACEUTICALS, INC.]7
FAMOTIDINE TABLET [LEGACY PHARMACEUTICAL PACKAGING, LLC]7
QUETIAPINE FUMARATE TABLET [CARDINAL HEALTH]7
SILDENAFIL TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]7
SIRINMEDI ONE (SODIUM MONOFLUOROPHOSPHATE) PASTE, DENTIFRICE [SUNGWON PHARMACEUTICAL CO., LTD.]7
APATITE (SODIUM MONOFLUOROPHOSPHATE) PASTE, DENTIFRICE [SUNGWON PHARMACEUTICAL CO., LTD.]6
CEFUROXIME AXETIL TABLET [PD-RX PHARMACEUTICALS, INC.]6
CLOPIDOGREL TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]6
DICLOFENAC POTASSIUM TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]6
ETODOLAC TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC]6
HYDROCODONE BITARTRATE AND IBUPROFEN TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]6
IRBESARTAN AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [WATSON LABORATORIES, INC.]6
LOSARTAN POTASSIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING, LLC]6
MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]6
NEWCHITO PLUS ONE (SODIUM MONOFLUOROPHOSPHATE) PASTE, DENTIFRICE [SUNGWON PHARMACEUTICAL CO., LTD.]6
BICALUTAMIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]5
CLOPIDOGREL TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING]5
IODENT MAXIMUM STRENGTH ORAL ANALGESIC (BENZOCAINE) GEL [UNITED EXCHANGE CORP]5
LEVETIRACETAM TABLET, FILM COATED [BLUEPOINT LABORATORIES]5
MEMATINE HYDROCHLORIDE TABLET, FILM COATED [ORCHID CHEMICALS & PHARMACEUTICALS LIMITED]5
PANTOPRAZOLE SODIUM TABLET [REMEDYREPACK INC. ]5
VORICONAZOLE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]5
AMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]4
DERMAN ANTIFUNGAL (ZINC UNDECYLENATE) CREAM [COMPANIA INTERNACIONAL DE COMERCIO, S.A.P.I DE C.V.]4
DOCU (DOCUSATE SODIUM) LIQUID [HI-TECH PHARMACAL CO., INC.]4
GUAIATUSSIN AC (GUAIFENESIN AND CODEINE PHOSPHATE) LIQUID [HI-TECH PHARMACAL CO., INC.]4
LANSOPRAZOLE CAPSULE, DELAYED RELEASE [BRECKENRIDGE PHARMACEUTICAL, INC.]4
LETROZOLE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]4
LEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC]4
PIOGLITAZONE AND METFORMIN HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]4

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 4R4HFI6D95 page 1 of 1 · 22 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683OINTMENTDENTALNA
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683INJECTIONINTRA-ARTICULAR3 %w/v
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683INJECTIONINTRAMUSCULAR3 %w/v
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683INJECTION, SUSPENSION, EXTENDED RELEASEINTRAMUSCULAR375 mg
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683INJECTIONINTRASYNOVIAL3 %w/v
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683INJECTION, POWDER, FOR SUSPENSIONINTRAVENOUS24 mg
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683CAPSULEORAL1659 mg
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683CAPSULE, DELAYED RELEASEORAL1.28 mg
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683CAPSULE, EXTENDED RELEASEORAL10.72 mg
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683GRANULEORAL83 mg
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683SOLUTIONORAL2667 mg
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683TABLETORAL83 mg
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683TABLET, COATEDORAL2 mg
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683TABLET, DELAYED RELEASEORAL90 mg
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683TABLET, EXTENDED RELEASEORAL433 mg
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683TABLET, FILM COATEDORAL5 mg
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683SUPPOSITORYRECTAL1269 mg
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683TABLETSUBLINGUAL2.5 mg
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683OINTMENTTOPICAL45 %w/w
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683SOLUTIONTOPICALNA
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683CREAMVAGINAL0.5 %w/w
POLYETHYLENE GLYCOL 40004R4HFI6D9525322683SUPPOSITORYVAGINALNA